A new wound dressing to help diabetic wounds heal faster
Engineering the open porous nanofibrous microsphere integrated fibrillar hydrogel for the co-delivery of antibacterial and angiogenic agents aimed at the rapid diabetic wound repair
['FUNDING_R01'] · TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION · NIH-11115753
This project is developing a special wound dressing that combines different materials to deliver medicines, helping diabetic wounds close quickly and prevent infection.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (nih funded) |
| Locations | 1 site (Woodland Hills, UNITED STATES) |
| Trial ID | NIH-11115753 on ClinicalTrials.gov |
What this research studies
We are creating a unique wound dressing made of tiny, porous spheres and a gel that responds to the body. This dressing is designed to encourage cells to move into the wound and form new tissue, which is key for fast healing. It will also release antibacterial agents to fight infection and other helpful substances to promote blood vessel growth. Our goal is to create a moist environment that supports healing and continuously delivers important medicines right where they are needed.
Who could benefit from this research
Good fit: This research is ultimately aimed at patients with diabetic wounds that are slow to heal or prone to infection.
Not a fit: Patients without diabetic wounds or those with wounds not caused by diabetes may not directly benefit from this specific wound dressing.
Why it matters
Potential benefit: If successful, this new wound dressing could significantly speed up the healing of diabetic wounds, reduce the risk of infection, and potentially prevent severe complications like amputation.
How similar studies have performed: Previous work has shown that porous nanofiber structures greatly improve cell migration and tissue integration, inspiring this novel, multi-component approach.
Where this research is happening
Woodland Hills, UNITED STATES
- TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION — Woodland Hills, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VITHARIKUNNIL JOHN, JOHNSON — TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION
- Study coordinator: VITHARIKUNNIL JOHN, JOHNSON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bacterial Infections